Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Phillips

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Journal of Hematotherapy|February 1, 1995
Quantitation, mobilization, and clinical use of long-term culture-initiating cells in blood cell autograftsH J Sutherland, D E Hogge, P M Lansdorp, et al.
Seminars in Oncology|June 1, 1987
Central nervous system effects of high-dose cytosine arabinosideR H Herzig, G P Herzig, S N Wolff, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Leukemia Research|January 1, 1986
Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemiaD E Reece, N A Buskard, R S Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant gliomaG L Phillips, S N Wolff, J W Fay, et al.
Blood|May 15, 1991
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988A Lohri, M Barnett, R N Fairey, et al.
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Journal of Hematotherapy|February 1, 1995
Quantitation, mobilization, and clinical use of long-term culture-initiating cells in blood cell autograftsH J Sutherland, D E Hogge, P M Lansdorp, et al.
Seminars in Oncology|June 1, 1987
Central nervous system effects of high-dose cytosine arabinosideR H Herzig, G P Herzig, S N Wolff, et al.
Leukemia|November 1, 1992
High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant GroupS N Wolff, R A Brown, J W Fay, et al.
Leukemia Research|January 1, 1986
Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemiaD E Reece, N A Buskard, R S Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant gliomaG L Phillips, S N Wolff, J W Fay, et al.
Blood|May 15, 1991
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988A Lohri, M Barnett, R N Fairey, et al.
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Pageof 16